Canine Arthritis Treatment Market Size

  • Report ID: 2972
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Canine Arthritis Treatment Market size was over USD 2.56 billion in 2024 and is poised to exceed USD 4.59 billion by 2037, growing at over 4.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of canine arthritis treatment is evaluated at USD 2.66 billion.

The growth of the market can be attributed to the growing prevalence of arthritis among dogs, especially in the bulkier breeds, such as, German shepherd, bulldog, and golden retrievers. Obesity in pets, along with lack of physical activities, are the major causes for arthritis in canines. The growing trend of keeping pets in the small urban apartments, where they do not get enough space for physical activities, is also one of the major causes for arthritis in dogs. These factors are estimated to drive the market growth. Moreover, rising number of animal NGOs and other volunteer organizations, that work for stray dogs, is estimated to further boost the market growth.



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of canine arthritis treatment is evaluated at USD 2.66 billion.

Canine Arthritis Treatment Market size was over USD 2.56 billion in 2024 and is poised to exceed USD 4.59 billion by 2037, growing at over 4.6% CAGR during the forecast period i.e., between 2025-2037.

North America industry is set to dominate majority revenue share by 2037, on the back of high pet population, in the U.S.

The major players in the market are Boehringer Ingelheim USA Corporation, Norbrook Laboratories Limited, American Regent, Inc., Vetoquinol S.A., Ceva Santé Animale, Elanco Animal Health Inc., Hill's Pet Nutrition, Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos